FREMONT, Calif.--(BUSINESS WIRE)--Confluent Medical Technologies (“Confluent Medical”), a global leader in medical device contract manufacturing, today completed the acquisition of Corpus Medical.
ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite ® Vascular Balloon-Expandable Stent System for the ...
Hosted on MSN
Drug-eluting balloon may be as safe, effective as conventional stents for repeat percutaneous coronary interventions
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...
The LMCA was engaged with an EBU 4 6 Fr guiding catheter through right radial approach.10000U of heparin was given. An Asahi soft guidewire was placed in Cx and balloon predilatation was made by 2x15 ...
Long-term follow-up of patients treated for drug-eluting stent restenosis following an initial PCI suggests that a drug-coated balloon (DCB) is just as safe and effective as a second round of stenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results